emily edmonds coordinator state pain forms pain interest group nursing issues
Post on 14-Feb-2016
26 Views
Preview:
DESCRIPTION
TRANSCRIPT
Ketamine Infusion Prescription and Observation Chart - adult
Education Slide Presentation
A presentation prepared by the Pain Interest Group Nursing Issues
in association with the Agency of Clinical Innovation Pain Management Network
Please direct comments to:
Emily EdmondsCoordinator State Pain Forms
Pain Interest Group Nursing IssuesCNC Acute Pain Service Blacktown Hospital
Phone: 9881 7649 Email: emily.edmonds@swahs.health.nsw.gov.au
Jenni JohnsonManager
Pain Management NetworkAgency for Clinical Innovation (ACI)
Phone: 9464 4636Email: jenni.johnsons@aci.health.nsw.gov.au
OR
March 21, 2013
2
Ketamine infusion Prescription and observation- adultThe ketamine infusion prescription and observation chart for adult patients has been
developed by a team of experts in the field of acute pain including clinical nurse consultants, anaesthetists and pharmacy representatives.
This chart has been designed for the administration of subcutaneous or intravenous ketamine infusions for patients who may have acute or chronic pain. The chart may not be appropriate for ketamine infusion administration in palliative care.
Standardisation of this chart promotes best practice in pain assessment and management of adverse effects in those patients who are receiving a ketamine infusion for pain management.
3
Aim of this presentation:
This presentation aims to explain how to use the chart to record the prescription,
administration and discarding of ketamine as a continuous infusion.
how to complete the clinical observations. guidelines on the management of patients who are
receiving ketamine as a continuous infusion including the management of adverse effects.
4
Ketamine infusion Prescription and observation chart - adult
Page 2 and Page 3: Left side: prescription (valid for 4 days)Right side: administration & discard
Front page: - Ketamine Infusion
- Management Guidelines & Clinical Review Criteria
Inside pages: Observation space for up to
4 days
Page 1 Page 2 Page 3
Inside pages
5
Prescription page:
Patient allergy status and patient label
Two revised prescription options
for alterations to ketamine prescription
Ketamine prescription:- Route- Amount- Additional drug & amount (if used)
- Diluent- Total volume- Concentration- Infusion rate- Infusion range (if used)
- Date, prescriber, pharmacy
Page 2
6
Prescription: Patient identificationHandwrite patient details
or affix patient label
(First prescriber to check patient label is correct)
Prescriber to complete patient allergy and ADR section in full
Prescription is valid for a maximum of 4 days unless
ceased earlierThe frequency of observations (2 hourly or 4 hourly)
must be determined by the medical officer
Private patients: require a
signature from the referring
Doctor to the Pain Service
7
Ketamine prescription: Options: set rate OR infusion range
Two further prescription boxes are provided for when alterations are indicated for the ketamine dose, concentration or infusion rate.
PLEASE REFER TO YOUR LOCAL HOSPITAL POLICY OR PROCEDURE FOR PREFERRED KETAMINE DELIVERY OPTIONS
Ketamine 200 mgIV
15/04/13 SMITHTSmith
50mL0.9% sodium chlorideNIL
4 mg41
4
1
8
2
8
Administration and discard of ketamine:
IF a ketamine syringe or bag is empty when the next is
commenced, document ‘NIL’ discarded
There are 12 more rows provided for more than
one syringe or bag of ketamine that is
commenced
Any ketamine remaining from a syringe or bag
MUST be recorded on the corresponding row from
its administration
10:0015/04/13 THal
l SRose 20:0015/04/13 BLo
hJLu
casNIL
20:00 BLoh JLucas 09:0017/04/13PLa
mbert
TBuckl
ey5 mL16/04/13
9
Clinical Review Criteria and Management Guidelines:
Ketamine Infusion
Management Guidelines
Clinical Review Criteria
Ketamine infusion
cessation prompt
(check local policy for use
of this prompt)
10
Observations
The ketamine chart can provide observations for a maximum of 4 days.
If the infusion continues beyond 4 days, a new chart must be started and
a new prescription written.
Inside pages
11
0900
1100
1300
1500
1700
01/03/2013
M M M
M M
R R R
R R
6mg
6mg
8mg
8mg
8mg
SH KL
SH KL
1000
1400
1800
2200
0200
15/04/13
A patient label must be affixed or details written
on each page that has recorded observations
Pain assessment:R = Rest
M = movement(If a PCA chart is in use – record
pain score on the PCA chart)
Dysphoric adverse effects assessment
(A score in the Yellow Zone requires a Clinical Review by the pain service)
Infusion rate (in mg or mL)
Ketamine pump program check
Subcutaneous or IV site check
Comments for free text
SHKL/AT
SH KLSH
NH
NH
Initial prompt
12
The standardisation of this chart promotes best practice in prescribing, pain assessment and management of adverse
effects in those patients receiving a ketamine infusion.
Comments or questions can be directed to your implementation officer or the project leaders Emily Edmonds or Jenni Johnson.
(contact details introduction slide)
The feedback register can be located on the ACI website:
http://www.aci.health.nsw.gov.au/networks/pain-management/acute-pain-forms
top related